142 related articles for article (PubMed ID: 37811306)
1. Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9859381. PubMed ID: 37811306
[TBL] [Abstract][Full Text] [Related]
2. lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma.
An L; Huang J; Ge S; Zhang X; Wang J
Comput Math Methods Med; 2022; 2022():1972516. PubMed ID: 35707044
[TBL] [Abstract][Full Text] [Related]
3. LncRNA AGAP2-AS1 interacts with IGF2BP2 to promote bladder cancer progression via regulating LRG1 mRNA stability.
Zhao X; Chen J; Zhang C; Xie G; Othmane B; Kuang X; Liu B
Cell Signal; 2023 Nov; 111():110839. PubMed ID: 37541640
[TBL] [Abstract][Full Text] [Related]
4. AGAP2-AS1: An Indispensable lncRNA in Tumors.
Chen J; Wang B
Mini Rev Med Chem; 2023; 23(3):336-342. PubMed ID: 35708074
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic roles and mechanisms of lncRNA AGAP2-AS1 in human solid tumors.
Bao Z; Zheng Q; Li L
Am J Transl Res; 2021; 13(2):757-769. PubMed ID: 33594324
[TBL] [Abstract][Full Text] [Related]
6. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
[No Abstract] [Full Text] [Related]
7. AGAP2-AS1/miR-628-5p/FOXP2 feedback loop facilitates the growth of prostate cancer via activating WNT pathway.
Zhao X; Liu Y; Luo C; Zuo Y
Carcinogenesis; 2021 Oct; 42(10):1270-1280. PubMed ID: 34255057
[TBL] [Abstract][Full Text] [Related]
8. EIF4A3 stabilizes the expression of lncRNA AGAP2-AS1 to activate cancer-associated fibroblasts via MyD88/NF-κb signaling.
Xu Q; Zhao T; Han H; Fan J; Xie W
Thorac Cancer; 2023 Feb; 14(5):450-461. PubMed ID: 36541122
[TBL] [Abstract][Full Text] [Related]
9. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
[TBL] [Abstract][Full Text] [Related]
10. Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression
Xie P; Liu M; Chen F; Wu S; Shao T; Wang W; Xu C; Zhou H
Front Genet; 2020; 11():1030. PubMed ID: 33101368
[TBL] [Abstract][Full Text] [Related]
11. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3.
Chen J; Peng X; Dai Y
Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485
[TBL] [Abstract][Full Text] [Related]
12. LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p/SLC7A11 signaling.
Zhang Y; Guo S; Wang S; Li X; Hou D; Li H; Wang L; Xu Y; Ma B; Wang H; Jiang X
Ecotoxicol Environ Saf; 2021 Sep; 220():112376. PubMed ID: 34051661
[TBL] [Abstract][Full Text] [Related]
13. SP1 induced long non-coding RNA AGAP2-AS1 promotes cholangiocarcinoma proliferation via silencing of CDKN1A.
Ji H; Wang J; Lu B; Li J; Zhou J; Wang L; Xu S; Peng P; Hu X; Wang K
Mol Med; 2021 Feb; 27(1):10. PubMed ID: 33522895
[TBL] [Abstract][Full Text] [Related]
14. LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer.
Hong S; Yan Z; Song Y; Bi M; Li S
Aging (Albany NY); 2020 Mar; 12(6):5183-5194. PubMed ID: 32202509
[TBL] [Abstract][Full Text] [Related]
15. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y
Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
17. Retracted: LncRNA OIP5-AS1 Knockdown Facilitated the Ferroptosis and Immune Evasion by Modulating the GPX4 in Oesophageal Carcinoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9872438. PubMed ID: 37416148
[TBL] [Abstract][Full Text] [Related]
18. AGAP2-AS1 serves as an oncogenic lncRNA and prognostic biomarker in glioblastoma multiforme.
Tian Y; Zheng Y; Dong X
J Cell Biochem; 2019 Jun; 120(6):9056-9062. PubMed ID: 30525219
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma.
Gao L; Zhao A; Wang X
Oncol Lett; 2020 Jun; 19(6):3993-4001. PubMed ID: 32382344
[TBL] [Abstract][Full Text] [Related]
20. Down-regulated lncRNA AGAP2-AS1 contributes to pre-eclampsia as a competing endogenous RNA for JDP2 by impairing trophoblastic phenotype.
Xu Y; Xia X; Jiang Y; Wu D; Wang S; Fu S; Yang N; Zhang Y; Sun L
J Cell Mol Med; 2020 Apr; 24(8):4557-4568. PubMed ID: 32150333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
